Published in J Neurosci on April 06, 2016
Pharmacokinetic Properties of Adenosine Amine Congener in Cochlear Perilymph after Systemic Administration. Biomed Res Int (2017) 0.75
NLRX1 accelerates cisplatin-induced ototoxity in HEI-OC1 cells via promoting generation of ROS and activation of JNK signaling pathway. Sci Rep (2017) 0.75
Role of STAT1 and Oxidative Stress in Gentamicin-Induced Hair Cell Death in Organ of Corti. Otol Neurotol (2016) 0.75
Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity. Redox Biol (2016) 0.75
Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. Cell Death Dis (2017) 0.75
Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency. Fluids Barriers CNS (2017) 0.75
Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell (1995) 10.16
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. Pharmacol Rev (2011) 4.16
Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science (1995) 3.10
Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science (1995) 3.07
Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol (1996) 2.55
Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol (1985) (1994) 2.37
Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol (1998) 2.37
NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem (2004) 2.36
Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res (2006) 2.28
Adenosine kinase, epilepsy and stroke: mechanisms and therapies. Trends Pharmacol Sci (2006) 1.83
Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol (1999) 1.80
Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol (1996) 1.75
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci (2004) 1.66
Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol (1994) 1.57
Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem (2001) 1.49
Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Oncogene (1998) 1.48
Serine phosphorylation and negative regulation of Stat3 by JNK. J Biol Chem (1999) 1.46
Protein kinase C delta associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J Biol Chem (1999) 1.41
Adenosine and brain ischemia. Cerebrovasc Brain Metab Rev (1992) 1.40
Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp Neurol (2006) 1.40
Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J Cereb Blood Flow Metab (2006) 1.37
Proinflammatory cytokines expression in noise-induced damaged cochlea. J Neurosci Res (2006) 1.36
The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther (2004) 1.31
Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB. J Assoc Res Otolaryngol (2007) 1.25
Noise-induced hearing loss in chinchillas pre-treated with glutathione monoethylester and R-PIA. Hear Res (2003) 1.22
Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype. J Assoc Res Otolaryngol (2006) 1.22
Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate. J Neurosci (2009) 1.18
Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat. J Neurosci (2008) 1.18
Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning. Am J Physiol Heart Circ Physiol (2005) 1.17
Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation. Cell Death Dis (2011) 1.16
The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategies. Recent Pat CNS Drug Discov (2010) 1.16
Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Antioxid Redox Signal (2010) 1.15
Sleep deprivation upregulates A1 adenosine receptors in the rat basal forebrain. Neuroreport (2007) 1.13
Auditory hair cell precursors immortalized from the mammalian inner ear. Proc Biol Sci (1998) 1.12
R-phenylisopropyladenosine attenuates noise-induced hearing loss in the chinchilla. Hear Res (1997) 1.12
Pathology of sensorineural hearing loss in otitis media. Ann Otol Rhinol Laryngol (1972) 1.11
Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia. Eur J Pharmacol (1994) 1.11
Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3. Oncogene (1999) 1.10
Inner ear supporting cells protect hair cells by secreting HSP70. J Clin Invest (2013) 1.10
Ototoxicity of the anticancer drug cisplatin. An experimental study. Acta Otolaryngol (1982) 1.08
Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. Neoplasia (2009) 1.07
Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1. J Assoc Res Otolaryngol (2008) 1.06
Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor kappa B. Mol Pharmacol (1998) 1.05
Direct interaction of adenosine with the TRPV1 channel protein. J Neurosci (2004) 1.04
RNA interference targeting of A1 receptor-overexpressing breast carcinoma cells leads to diminished rates of cell proliferation and induction of apoptosis. Cancer Biol Ther (2005) 1.00
Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes. Clin Cancer Res (2001) 0.96
Adenosine suppresses CW2 human colonic cancer growth by inducing apoptosis via A(1) adenosine receptors. Cancer Lett (2009) 0.95
Ototoxicity: mechanisms of cochlear impairment and its prevention. Curr Med Chem (2011) 0.95
Characterization of a murine high-affinity thiamine transporter, Slc19a2. Mol Genet Metab (2001) 0.94
Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment. Neurosci Lett (1989) 0.93
Up-regulation of adenosine receptors in the cochlea by cisplatin. Hear Res (1997) 0.93
Differential distribution of adenosine receptors in rat cochlea. Cell Tissue Res (2007) 0.93
NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss. Antioxid Redox Signal (2010) 0.92
Adenosine A receptors are necessary for protection of the murine heart by remote, delayed adaptation to ischaemia. Acta Physiol Scand (2004) 0.91
Induction of adenosine A1 receptor expression by pertussis toxin via an adenosine 5'-diphosphate ribosylation-independent pathway. J Pharmacol Exp Ther (2005) 0.91
A human temporal bone study of acute bacterial meningogenic labyrinthitis. Am J Otol (1996) 0.88
Expression and function of adenosine receptors in the chinchilla cochlea. Hear Res (1997) 0.87
Protection against cisplatin ototoxicity by adenosine agonists. Biochem Pharmacol (2004) 0.87
Osmotic diuretics induce adenosine A1 receptor expression and protect renal proximal tubular epithelial cells against cisplatin-mediated apoptosis. J Biol Chem (2004) 0.85
Activation of the adenosine A1 receptor inhibits HIV-1 tat-induced apoptosis by reducing nuclear factor-kappaB activation and inducible nitric-oxide synthase. Mol Pharmacol (2007) 0.85
Adenosine amine congener mitigates noise-induced cochlear injury. Purinergic Signal (2010) 0.85
Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK. Toxicol Lett (2010) 0.85
Adenosine and the auditory system. Curr Neuropharmacol (2009) 0.83
siRNA-mediated knock-down of NOX3: therapy for hearing loss? Cell Mol Life Sci (2012) 0.82
Cisplatin cytotoxicity in organ of Corti-derived immortalized cells. J Cell Biochem (2007) 0.82
Identification of A1 adenosine receptors in rat cochlea coupled to inhibition of adenylyl cyclase. Am J Physiol (1994) 0.80
Protective effect of cyclohexyladenosine on adenosine A1-receptors, guanine nucleotide and forskolin binding sites following transient brain ischemia: a quantitative autoradiographic study. Brain Res (1989) 0.80
Adenosine kinase inhibition in the cochlea delays the onset of age-related hearing loss. Exp Gerontol (2011) 0.80
Comparison of the effect of cyclic AMP on the content and release of dopamine and 1-methyl-4-phenylpyridinium (Mpp+) in PC12 cells. Auton Autacoid Pharmacol (2003) 0.77
Anticonvulsant action of 2-chloroadenosine injected focally into the inferior colliculus and substantia nigra. Eur J Pharmacol (1991) 0.77
Adenosine is a modulator of hair cell-afferent neurotransmission. Hear Res (1987) 0.77
NOX3-TARGETED THERAPIES FOR INNER EAR PATHOLOGIES. Curr Pharm Des (2015) 0.76
The effect of adenosine on cochlear potentials in the guinea pig. Eur Arch Otorhinolaryngol (1994) 0.76